About ALSF

First-in-human clinical trial aims to treat neuroblastoma

 » View all news titles
 » View titles this week
» View titles this month

Baylor College of Medicine


Neuroblastoma is the most common extracranial solid tumor cancer in children, and patients with high-risk disease are challenging to treat. In a promising development, researchers at Baylor College of Medicine announced a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using genetically engineered natural killer T cells (NKTs).

>>Read more